Cognitive Behavioral Therapy for Arthritis Pain and Insomnia in Older Adults (Lifestyles)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01142349 |
Recruitment Status :
Completed
First Posted : June 11, 2010
Last Update Posted : December 19, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Pain Dysfunction Sleep Disturbance Osteoarthritis | Behavioral: Lifestyles A Behavioral: Lifestyles B Behavioral: Lifestyles C | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 367 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Cognitive Behavioral Therapy for Arthritis Pain and Insomnia in Older Adults |
Study Start Date : | January 2009 |
Actual Primary Completion Date : | August 2013 |
Actual Study Completion Date : | August 2013 |

Arm | Intervention/treatment |
---|---|
Experimental: Lifestyles A
Cognitive Behavioral Therapy for Pain and Insomnia
|
Behavioral: Lifestyles A
Six weekly group sessions that last about 90-120 minutes presenting cognitive behavioral therapy for pain and insomnia |
Experimental: Lifestyle B
Cognitive Behavioral Therapy for Pain
|
Behavioral: Lifestyles B
Six weekly group sessions that last about 90-120 minutes presenting cognitive behavioral therapy for pain. |
Active Comparator: Lifestyles C
Osteoarthritis Education
|
Behavioral: Lifestyles C
Six weekly group sessions that last about 90-120 minutes presenting osteoarthritis education. |
- Insomnia Severity Index (ISI) [ Time Frame: Baseline ]A 7-item self-report screening measure that rates severity of sleep problems, interference with daily functioning, and participant distress over symptoms. Rated on a scale from 0 (no problems) to 4 (very much a problem).
- Insomnia Severity Index (ISI) [ Time Frame: Post treatment- 2 months post baseline assessment ]A 7-item self-report screening measure that rates severity of sleep problems, interference with daily functioning, and participant distress over symptoms. Rated on a scale from 0 (no problems) to 4 (very much a problem).
- Insomnia Severity Index (ISI) [ Time Frame: 9 months post baseline assessment ]A 7-item self-report screening measure that rates severity of sleep problems, interference with daily functioning, and participant distress over symptoms. Rated on a scale from 0 (no problems) to 4 (very much a problem).
- Insomnia Severity Index (ISI) [ Time Frame: 18 months post baseline assessment ]A 7-item self-report screening measure that rates severity of sleep problems, interference with daily functioning, and participant distress over symptoms. Rated on a scale from 0 (no problems) to 4 (very much a problem).
- Global Pain Severity-Graded Chronic Pain Scale [ Time Frame: Baseline ]The Global Pain Severity Scale derived from the Graded Chronic Pain Scale consists of three 0-10 pain intensity ratings (pain right now, average pain, and worst pain in the prior month) and three 0-10 pain interference ratings (interference with daily activities, recreational, social and family activites, and ability to work including housework).
- Global Pain Severity-Graded Chronic Pain Scale [ Time Frame: Post treatment-2 mos. post baseline ]The Global Pain Severity Scale derived from the Graded Chronic Pain Scale consists of three 0-10 pain intensity ratings (pain right now, average pain, and worst pain in the prior month) and three 0-10 pain interference ratings (interference with daily activities, recreational, social and family activites, and ability to work including housework).
- Global Pain Severity-Graded Chronic Pain Scale [ Time Frame: 9 months post baseline assessment ]The Global Pain Severity Scale derived from the Graded Chronic Pain Scale consists of three 0-10 pain intensity ratings (pain right now, average pain, and worst pain in the prior month) and three 0-10 pain interference ratings (interference with daily activities, recreational, social and family activites, and ability to work including housework).
- Global Pain Severity- Graded Chronic Pain Scale [ Time Frame: 18 months post baseline assessment ]The Global Pain Severity Scale derived from the Graded Chronic Pain Scale consists of three 0-10 pain intensity ratings (pain right now, average pain, and worst pain in the prior month) and three 0-10 pain interference ratings (interference with daily activities, recreational, social and family activites, and ability to work including housework).

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 60 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age 60+
- Continuously enrolled in Group Health one year prior to sample pull
- Primary care clinic at selected clinics
- Not in "No Contact File"
- Diagnosis 715xx (Osteoarthritis) in prior three years
Exclusion Criteria:
- Not continuously enrolled in Group Health for at least one year
-
Medical record information indicates a diagnosis of:
- rheumatoid arthritis
- obstructive sleep apnea
- periodic leg movement disorder
- restless leg syndrome
- sleep-wake cycle disturbance
- rapid eye movement (REM) behavior disorder
- dementia or receiving cholinesterase inhibitors
- Parkinson's disease or other neurodegenerative disease known to directly impact sleep
- cancer in the past year and receiving chemotherapy or radiation therapy in the past year
- inpatient treatment for congestive heart failure within the previous 6 months

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01142349
United States, Washington | |
Group Health Research Institute | |
Seattle, Washington, United States, 98101 | |
University of Washington | |
Seattle, Washington, United States, 98115 |
Principal Investigator: | Michael V Vitiello, Ph.D. | University of Washington | |
Principal Investigator: | Susan M McCurry, Ph.D. | University of Washington | |
Principal Investigator: | Michael Von Korff, Sc.D. | Group Health Research Institute | |
Principal Investigator: | Ben Balderson, Ph.D. | Group Health Research Institute |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Michael Vitiello, Professor, University of Washington |
ClinicalTrials.gov Identifier: | NCT01142349 |
Other Study ID Numbers: |
R01AG031126 ( U.S. NIH Grant/Contract ) R01AG031126 ( U.S. NIH Grant/Contract ) |
First Posted: | June 11, 2010 Key Record Dates |
Last Update Posted: | December 19, 2013 |
Last Verified: | December 2013 |
Arthritis Group Program Pain Insomnia Pain dysfunction and sleep disturbance among older adults with osteoarthritis. |
Arthritis Osteoarthritis Sleep Initiation and Maintenance Disorders Dyssomnias Parasomnias Joint Diseases |
Musculoskeletal Diseases Rheumatic Diseases Sleep Disorders, Intrinsic Sleep Wake Disorders Nervous System Diseases Mental Disorders |